Medical Marijuana, Inc. carries a market capitalization of 568,945.00, placing it among publicly traded companies globally. Its enterprise value stands at 314.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 568,945.00 |
| Enterprise Value | 314.69M |
Medical Marijuana, Inc. currently has 3.44B shares outstanding.
| Shares Outstanding | 3.44B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 5.98, and the price-to-book ratio stands at -3.24.
| PE Ratio | N/A |
| PS Ratio | 5.98 |
| PB Ratio | -3.24 |
| P/TBV Ratio | 6.95 |
| P/FCF Ratio | -0.96 |
| P/OCF Ratio | -0.96 |
| EV / Sales | 6.10 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Medical Marijuana, Inc. maintains a current ratio of 3.75, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.38, indicating elevated leverage, while an interest coverage ratio of -1.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.75 |
| Quick Ratio | 2.09 |
| Debt / Equity | 10.38 |
| Debt / EBITDA | -2.29 |
| Interest Coverage | -1.05 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -141.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.08 |
Medical Marijuana, Inc.'s stock has declined approximately -50% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Medical Marijuana, Inc. generated 51.59M in revenue and converted that into -318.92M in net income, yielding earnings per share of -0.09. EBITDA reached -4.06M, while operating income came in at -4.06M.
| Revenue | 51.59M |
| Gross Profit | 34.69M |
| Operating Income | -4.06M |
| Pretax Income | -313.02M |
| Net Income | -318.92M |
| EBITDA | -4.06M |
| EBIT | -4.06M |
| Earnings Per Share (EPS) | -0.09 |
Medical Marijuana, Inc. holds 3.27M in cash and equivalents against 9.32M in total debt, resulting in a net debt position of 6.04M. Total book value stands at -95.41M, with working capital of 10.91M providing operational flexibility.
| Cash & Cash Equivalents | 3.27M |
| Total Debt | 9.32M |
| Net Debt | 6.04M |
| Equity (Book Value) | -95.41M |
| Book Value Per Share | -0.03 |
| Working Capital | 10.91M |
Medical Marijuana, Inc. produced -323.06M in operating cash flow over the past twelve months.
| Operating Cash Flow | -323.06M |
| Capital Expenditures | N/A |
| Free Cash Flow | -323.06M |
| FCF Per Share | -0.09 |
Medical Marijuana, Inc. operates with a gross margin of 67.25, reflecting its pricing power and cost economics. The operating margin of -7.86 and net profit margin of -618.23 provide insight into operational efficiency.
| Gross Margin | 67.25 |
| Operating Margin | -7.86 |
| Pretax Margin | -606.78 |
| Profit Margin | -618.23 |
| EBITDA Margin | -7.87 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -25.20 |
| FCF Yield | -104.46 |
Medical Marijuana, Inc.'s most recent stock split took place on April 28, 2009 with a 1:10 split ratio.
| Last Split Date | 4/28/2009 |
| Split Ratio | 1:10 |
Medical Marijuana, Inc. posts an Altman Z-Score of 12.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.43 |